Skip to content

Effect of target-directed fluid therapy on maternal and infant outcomes in elderly primiparas undergoing cesarean section

Effect of target-directed fluid therapy on maternal and infant outcomes in elderly primiparas undergoing cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068420
Enrollment
Unknown
Registered
2023-02-17
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly maternal

Interventions

Goal-direct fluid therapy group:Goal-direct fluid therapy
Control group:Guide liquid infusion according to the experience of anesthesiologists

Sponsors

Women' Hosipital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 35-45 years; single term, gestational>37weeks; BMI <=35 kg/m^2; no contraindication of spinal block.

Exclusion criteria

Exclusion criteria: Heart failure, pre-eclampsia or uncontrolled hypertension (SBP>180mmHg) , preoperative need for vasoactive drugs to maintain blood pressure, liver and kidney failure, and inability to obtain good ultrasound images Failure of spinal canal block or poor anesthetic effect.

Design outcomes

Primary

MeasureTime frame
First exhaust time;Incidence rate of hypotension;

Secondary

MeasureTime frame
BMI;gestation week;fasting time;blood loss;urine volume;Infusion volume;adverse reaction;First off-bed time;length of stay;Blood gas analysis of umbilical artery;Apgar score;the fetus to NICU;blood pressure;heart rate;Stroke volume;Cardiac output;age;Vasoactive drug;

Countries

China

Contacts

Public ContactFeng Shanwu

Nanjing maternal and child health care hospital

iamfsw@163.com+86 139 2142 6351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026